Ulriche Denis

Title: Ulriche Denis: Innovator in Diabetic Retinopathy Treatment

Introduction

Ulriche Denis is a notable inventor based in Caluire et Cuire, France. He has made significant contributions to the field of medical science, particularly in the treatment of diabetic retinopathy. His innovative approach has led to the development of a unique method that addresses a critical health issue affecting many individuals.

Latest Patents

Ulriche Denis holds 1 patent for his work titled "Methods of treating diabetic retinopathy with pericyte apoptosis inhibitors." This patent discloses a method for preventing or treating diabetic retinopathy by administering a therapeutically effective amount of an inhibitor of retinal pericyte apoptosis. Additionally, it includes a pharmaceutical composition designed to treat and/or prevent diabetic retinopathy, which comprises a therapeutically effective amount of at least one inhibitor of retinal pericyte apoptosis along with a pharmaceutically acceptable carrier.

Career Highlights

Throughout his career, Ulriche Denis has worked with prominent organizations such as Merck Santé and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to refine his research and contribute to advancements in medical treatments.

Collaborations

Ulriche Denis has collaborated with several professionals in his field, including Marc Lecomte and Clarisse Paget. These partnerships have facilitated the exchange of ideas and fostered innovation in the treatment of diabetic retinopathy.

Conclusion

Ulriche Denis stands out as an inventor dedicated to improving healthcare through innovative solutions. His work in diabetic retinopathy treatment exemplifies the impact of research and collaboration in the medical field.